Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
| Actual shortage: | 243 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2017-03-10 | 2017-04-21 | 21 |
| APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2017-07-26 | 2017-12-31 | 17198 |
| APO-GABAPENTIN | 800MG | TABLET | Resolved | 2017-09-26 | 2017-10-31 | 23558 |
| APO-GABAPENTIN | 800MG | TABLET | Resolved | 2017-11-28 | 2018-03-22 | 31004 |
| APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2018-01-17 | 2018-01-31 | 36257 |
| APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2018-03-05 | 2018-07-03 | 41841 |
| APO-GABAPENTIN | 800MG | TABLET | Resolved | 2019-03-27 | 2019-05-21 | 79580 |
| APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2019-07-12 | 2019-08-31 | 89152 |
| APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2022-04-08 | 2022-05-25 | 158345 |
| APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174642 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2021-08-27 | 2021-11-19 | 144656 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2022-03-18 | 2022-04-01 | 156983 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2022-06-06 | 2022-07-22 | 162091 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2023-02-16 | 2023-03-02 | 185025 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2023-12-08 | 2024-01-19 | 212940 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Actual shortage | 2024-02-16 | 2024-05-03 | 219843 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2021-05-07 | 2021-05-26 | 138954 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2021-10-29 | 2021-11-08 | 148491 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2022-02-04 | 2022-04-01 | 154168 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2022-12-16 | 2023-03-02 | 178793 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |